Friday, October 29, 2021

Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand

Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.

from Latest News https://ift.tt/3EsXDNW
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

Related Posts:

0 comments: